[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349825-105":59,"doc-detail-349825-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","research-article-p53-drives-lung-cancer-regression-through-a-tsc2tfeb-dependent-senescence-program","ReseaRch aRticle - p53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent Senescence Program","","Pharmacologic restoration of p53 is a promising therapeutic concept for cancers with compromised p53 activity, including lung adenocarcinoma, yet the p53 pathway has been considered difficult to drug. Using mouse and human models, researchers deconstruct transcriptional programs driving robust therapeutic responses in lung adenocarcinoma. Results show p53 triggers Tsc2 transactivation, mTORC1 inhibition, and TFEB nuclear accumulation, activating lysosomal gene expression, autophagy, and cellular senescence, which then promotes macrophage recruitment and tumor regression.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/research-article-p53-drives-lung-cancer-regression-through-a-tsc2tfeb-dependent-senescence-program/349825/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/research-article-p53-drives-lung-cancer-regression-through-a-tsc2tfeb-dependent-senescence-program/349825.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is restoring p53 considered an appealing therapy for lung adenocarcinoma?","Question",{"text":113,"@type":114},"Restoring p53 tumor suppressor function targets tumors with compromised p53 activity, and restoration of wild-type p53 in established KrasG12D;p53-deficient lung adenocarcinomas induces tumor regression in mice.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What cascade links p53 activation to tumor regression in this study?",{"text":118,"@type":114},"p53 drives tumor regression through direct Tsc2 transactivation, which inhibits mTORC1 and causes TFEB nuclear accumulation, leading to lysosomal gene programs, autophagy, and cellular senescence.",{"name":120,"@type":111,"acceptedAnswer":121},"How do senescent lung adenocarcinoma cells contribute to regression?",{"text":122,"@type":114},"Senescent cancer cells secrete factors that recruit macrophages, which precipitate cancer cell phagocytosis and thereby support tumor regression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349825,1791078506,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","ReseaRch aRticle  \np53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent  \nSenescence Program   \nMengxiong Wang1, Kathryn T. Bieging-Rolett1, Alyssa M. Kaiser1, Colleen A. Brady1, John H. Lockhart2,3, Sofia Ferreira1, Kha T. Nguyen1, Arati Rajeevan1, Simone A. Evans4, Tianyu Zhao1, Nitin Raj1,  \nArielle Elkrief5,6, Sam E. Tischfield7, Marc Ladanyi5, Michael G. Ozawa8, Nam Q. Bui9, Christopher T. Chen9, Elsa R. Flores2,3, and Laura D. Attardi1,4  \nPharmacologic restoration of p53 tumor suppressor function is a conceptually  \nappealing therapeutic strategy for the many deadly cancers with compromised p53 activity, including lung adenocarcinoma. However, the p53 pathway has remained undruggable, partly because of insufficient understanding of how to drive effective therapeutic responses without toxicity. In this study, we use mouse and human models to deconstruct the transcriptional programs and sequelae underlying robust therapeutic responses in lung adenocarcinoma. We show that p53 drives potent tumor regression by direct Tsc2 transactivation, leading to mTORC1 inhibition and Transcription factor EB (TFEB) nuclear accumulation, which in turn triggers lysosomal gene expression programs, autophagy, and cellular senescence. Senescent lung adenocarcinoma cells secrete factors to recruit macrophages, precipitating cancer cell phagocytosis and tumor regression. Collectively, our analyses reveal a surprisingly complex cascade of events underlying a p53 therapeutic response in lung adenocarcinoma and illuminate targetable nodes for p53 combination therapies, thus establishing a critical framework for optimizing p53-based therapeutics.  \nSigniFiCAnCE: Cancer therapies based on targeting the p53 pathway remain elusive. To address this gap, we unravel the detailed sequence of events governing p53-induced tumor regression in lung adenocarcinoma. These analyses reveal a TSC2–mTORC1–TFEB axis underlying p53-driven senescence and tumor regression, which suggests new strategies to perfect p53-based combination therapies for lung adenocarcinoma.  \nintRoduction  \nLung cancer is the leading cause of cancer deaths worldwide, and lung adenocarcinoma is the most prevalent typeof lung cancer (1) . Lung adenocarcinoma originates in the alveoli of the lungs, the sacs that mediate gas exchange, predominantly from alveolar type 2 (AT2) cells (2, 3) . Oncogenic mutations in genes such as KRAS, which encodes the KRAS signaling protein, induce the transformation of AT2 cells toa tumorigenic state (reviewed in ref. 4) . However, studies in mouse models have shown that AT2 cells with an oncogenic Kras mutation alone rarely progress beyond adenomas (5) .  \n1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California. 2Department of Molecular Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida.  \n3Cancer Biology and Evolution Program, H. Lee Moffitt Cancer Center, Tampa, Florida. 4Department of Genetics, Stanford University School of Medicine, Stanford, California. 5Department of Pathology and Laboratory Medicine, and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. 6Centre hospitalierde l’Université de Montréal (CHUM), Department of Hemato-Oncology, University of Montréal, Montreal, Canada. 7Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. 8Department of Pathology, Stanford University School of Medicine, Stanford, California. 9Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California.  \nCorresponding Author: Laura D. Attardi, Stanford University, CCSRSouth, Room 1255, 269 Campus Drive, Stanford, CA 94305. E-mail: [attardi@stanford.edu](attardi@stanford.edu)  \nCancer Discov 2026;16:391–411  \ndoi: 10. 1158/2159-8290 . CD-25-0525  \nThis open access article is distributed under the Creative Commons Attribu","cbCaialNmFque5lq","https://ap.wps.com/l/cbCaialNmFque5lq","pdf",19427029,21,"English","# Introduction\n## Lung adenocarcinoma background and oncogenic KRAS\n## p53 loss, therapeutic rationale, and restoration strategies","[{\"question\":\"Why is restoring p53 considered an appealing therapy for lung adenocarcinoma?\",\"answer\":\"Restoring p53 tumor suppressor function targets tumors with compromised p53 activity, and restoration of wild-type p53 in established KrasG12D;p53-deficient lung adenocarcinomas induces tumor regression in mice.\"},{\"question\":\"What cascade links p53 activation to tumor regression in this study?\",\"answer\":\"p53 drives tumor regression through direct Tsc2 transactivation, which inhibits mTORC1 and causes TFEB nuclear accumulation, leading to lysosomal gene programs, autophagy, and cellular senescence.\"},{\"question\":\"How do senescent lung adenocarcinoma cells contribute to regression?\",\"answer\":\"Senescent cancer cells secrete factors that recruit macrophages, which precipitate cancer cell phagocytosis and thereby support tumor regression.\"}]","ReseaRch aRticle - p53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent Senescence Program | PDF",1790085820,53,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c68bfceb4f9396234f635e030042ae26.webp",983,1315,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b495271d5d3c13ac81c7442514b9761.webp",982,1314,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70f8cadae847e57cdfc3b5b0a8622868.webp",981,1312,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3e18c5940178652d3d21f7139368a82.webp",980,1311]